Crystalvue Medical Corporation (TPEX:6527)
Taiwan
· Delayed Price · Currency is TWD 67.10
-0.10 (-0.15%)
Apr 29, 2026, 1:30 PM CST
Crystalvue Medical Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 1,700 | 1,929 | 2,152 | 2,190 | 1,241 | 1,144 | Upgrade
|
| Market Cap Growth | -20.40% | -10.37% | -1.77% | 76.51% | 8.45% | -3.52% | Upgrade
|
| Enterprise Value | 1,580 | 1,836 | 1,898 | 2,009 | 1,092 | 1,121 | Upgrade
|
| Last Close Price | 67.10 | 76.10 | 82.74 | 82.52 | 46.15 | 40.72 | Upgrade
|
| PE Ratio | 11.77 | 13.12 | 16.92 | 21.18 | 10.79 | 14.82 | Upgrade
|
| PS Ratio | 1.79 | 2.03 | 2.48 | 2.66 | 1.56 | 1.59 | Upgrade
|
| PB Ratio | 1.65 | 1.88 | 2.29 | 2.56 | 1.60 | 1.59 | Upgrade
|
| P/TBV Ratio | 1.66 | 1.88 | 2.30 | 2.57 | 1.60 | 1.59 | Upgrade
|
| P/FCF Ratio | - | - | 95.13 | 14.64 | 28.05 | - | Upgrade
|
| P/OCF Ratio | 12.22 | 13.86 | 14.06 | 14.22 | 23.97 | 18.09 | Upgrade
|
| EV/Sales Ratio | 1.66 | 1.93 | 2.19 | 2.44 | 1.37 | 1.55 | Upgrade
|
| EV/EBITDA Ratio | 8.04 | 9.65 | 11.45 | 14.40 | 7.59 | 9.15 | Upgrade
|
| EV/EBIT Ratio | 8.73 | 10.15 | 13.09 | 17.07 | 8.75 | 12.67 | Upgrade
|
| EV/FCF Ratio | -35.19 | - | 83.93 | 13.42 | 24.69 | - | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.03 | 0.04 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.06 | 0.06 | 0.11 | 0.17 | 0.21 | 0.29 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.82 | 0.17 | 0.71 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.12 | -0.12 | -0.24 | -0.29 | -0.19 | -0.22 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.63 | -0.63 | -1.35 | -1.78 | -1.01 | -1.27 | Upgrade
|
| Net Debt / FCF Ratio | 2.68 | 2.68 | -9.87 | -1.66 | -3.28 | 0.54 | Upgrade
|
| Asset Turnover | 0.77 | 0.77 | 0.77 | 0.79 | 0.82 | 0.79 | Upgrade
|
| Inventory Turnover | 2.40 | 2.40 | 2.08 | 2.05 | 2.36 | 2.88 | Upgrade
|
| Quick Ratio | 1.44 | 1.44 | 1.84 | 1.97 | 1.62 | 1.62 | Upgrade
|
| Current Ratio | 2.45 | 2.45 | 3.00 | 3.46 | 2.90 | 2.75 | Upgrade
|
| Return on Equity (ROE) | 14.94% | 14.94% | 14.16% | 12.67% | 15.39% | 11.08% | Upgrade
|
| Return on Assets (ROA) | 9.12% | 9.12% | 8.01% | 7.03% | 7.99% | 6.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.45% | 18.30% | 17.47% | 16.40% | 16.89% | 15.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 17.50% | 17.50% | 15.20% | 13.40% | 15.50% | 11.80% | Upgrade
|
| Earnings Yield | 8.64% | 7.62% | 5.91% | 4.72% | 9.27% | 6.75% | Upgrade
|
| FCF Yield | -2.64% | -2.33% | 1.05% | 6.83% | 3.56% | -25.16% | Upgrade
|
| Dividend Yield | 4.32% | 3.81% | 2.72% | 2.51% | 4.95% | 4.54% | Upgrade
|
| Payout Ratio | 38.79% | 38.79% | 41.13% | 54.90% | 40.25% | 43.26% | Upgrade
|
| Buyback Yield / Dilution | -0.30% | -0.30% | -1.64% | 0.91% | -0.53% | 0.99% | Upgrade
|
| Total Shareholder Return | 3.95% | 3.51% | 1.08% | 3.41% | 4.42% | 5.53% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.